Metropolitan Life Insurance Company (MetLife)’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,270
| Closed | -$8.64K | – | 441 |
|
|
2024
Q1 | $8.64K | Hold |
1,270
| – | – | ﹤0.01% | 2178 |
|
|
2023
Q4 | $8.62K | Hold |
1,270
| – | – | ﹤0.01% | 2225 |
|
|
2023
Q3 | $6.36K | Hold |
1,270
| – | – | ﹤0.01% | 2373 |
|
|
2023
Q2 | $9.2K | Buy |
+1,270
| New | +$9.2K | ﹤0.01% | 2337 |
|
|
2021
Q4 | – | Sell |
-5,911
| Closed | -$105K | – | 2791 |
|
|
2021
Q3 | $105K | Hold |
5,911
| – | – | ﹤0.01% | 2493 |
|
|
2021
Q2 | $113K | Buy |
+5,911
| New | +$113K | ﹤0.01% | 2533 |
|